USA — Thermo Fisher Scientific, a leading medical technology company based in the United States, has launched Diomni Enterprise Software to address challenges associated with manual molecular testing workflows.
Diomni is specifically designed to connect various steps within a unified interface, simplifying routine diagnostics testing, standardizing processes, and reducing time-to-results.
The software is aimed at developers and laboratories conducting routine quantitative polymerase chain reaction (qPCR) diagnostic tests. It provides a rapid and efficient platform for the development of emerging testing solutions.
Thermo Fisher Scientific’s Diomni Enterprise supports different types of testing workflows, including both research-use-only and in-vitro diagnostic assays and instruments.
The software offers enhanced flexibility to accommodate the evolving needs of laboratories and assay developers.
Fernando Beils, Vice President and General Manager of qPCR Instruments at Thermo Fisher Scientific, highlighted the company’s response to the challenges faced by clinical labs during the pandemic.
They quickly launched the initial stages of the Diomni solution, which provided a digital platform supporting testing workflows while adapting to the rapidly changing PCR testing landscape.
Building upon this foundation, Thermo Fisher Scientific is excited to deliver a more robust and scalable tool that addresses the needs of labs and assay developers in various testing environments.
Outdated systems often plague molecular diagnostics labs and test kit manufacturers, hindering throughput enhancement and expanding the test menu.
Additionally, manual and inefficient steps make it challenging to track samples and maintain compliance, both of which are crucial for molecular diagnostics laboratories.
Thermo Fisher Scientific’s Diomni Enterprise Software effectively connects individual workflow steps within a single, unified platform, significantly improving the productivity of qPCR workflows.
It enhances operational efficiency by automating the interface with existing laboratory information systems (LIS) and ensures enhanced traceability.
By consolidating labs, instruments, assays, and LIS on a single system, Diomni provides increased traceability throughout the sample journey, enabling efficient sample and reagent tracking.
Furthermore, the software allows multiple users to access assay templates and results simultaneously, facilitating seamless collaboration.
Thermo Fisher Scientific’s introduction of Diomni Enterprise Software marks a significant step forward in streamlining molecular testing workflows, optimizing laboratory productivity, and ensuring accurate and efficient diagnostics.
The software’s capabilities have the potential to revolutionize routine diagnostics testing and contribute to advancements in the field of molecular diagnostics.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.
